Your browser doesn't support javascript.
loading
Molecular Response of e19a2 BCR-ABL1 Chronic Myeloid Leukemia With Double Philadelphia Chromosome to Dasatinib.
Ikeda, Kazuhiko; Harada-Shirado, Kayo; Matsumoto, Hayato; Noji, Hideyoshi; Ogawa, Kazuei; Takeishi, Yasuchika.
Affiliation
  • Ikeda K; Fukushima Medical University, Fukushima, Japan kazu-ike@fmu.ac.jp.
  • Harada-Shirado K; Fukushima Medical University, Fukushima, Japan.
  • Matsumoto H; Fukushima Medical University, Fukushima, Japan.
  • Noji H; Fukushima Medical University, Fukushima, Japan.
  • Ogawa K; Fukushima Medical University, Fukushima, Japan.
  • Takeishi Y; Fukushima Medical University, Fukushima, Japan.
J Clin Oncol ; 34(14): e130-3, 2016 05 10.
Article in En | MEDLINE | ID: mdl-24752059
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Philadelphia Chromosome / Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Fusion Proteins, bcr-abl / Dasatinib / Antineoplastic Agents Limits: Aged / Female / Humans Language: En Journal: J Clin Oncol Year: 2016 Type: Article Affiliation country: Japan
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Philadelphia Chromosome / Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Fusion Proteins, bcr-abl / Dasatinib / Antineoplastic Agents Limits: Aged / Female / Humans Language: En Journal: J Clin Oncol Year: 2016 Type: Article Affiliation country: Japan